dgcr8 knockout dgcr8 mouse escs (Novus Biologicals)
Structured Review

Dgcr8 Knockout Dgcr8 Mouse Escs, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 14 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nba1+19349/pmc06529217-146-0-11?v=Novus+Biologicals
Average 90 stars, based on 14 article reviews
Images
1) Product Images from "MicroRNA-deficient mouse embryonic stem cells acquire a functional interferon response"
Article Title: MicroRNA-deficient mouse embryonic stem cells acquire a functional interferon response
Journal: eLife
doi: 10.7554/eLife.44171
Figure Legend Snippet: ( a ) (left) Susceptibility (TCID 50 /ml) of miRNA deficient cells ( Dgcr8 -/- , Dicer -/- ) and wild-type parental cells ( Dgcr8 +/+ (ESC1), Dicer +/+ (ESC2)) to TMEV infection, higher values represent higher susceptibility (n = 4, p-value<0.05, t-test). (right) Quantification of Influenza A replication after infection of the same cell lines, data show the average (n = 3)±s.d. (*) p-value<0.05 by t-test. ( b ) Quantification of Ifnb1 expression of ESCs lacking Dgcr8 or Dicer to stimulation with poly(I:C) and G 3 -YSD. Data show average (n = 3)±s.d., normalized to mock, (*) p-value<0.05 by t-test. ( c ) Quantification of TMEV vRNA upon JAK1/2 inhibition by Ruxolitinib treatment. Data show the average (n = 3)±s.d. ( d ) qRT-PCR analyses of ISGs expression after stimulation of wild-type and miRNA-deficient ESCs with IFN-β. Data show average (n = 3)±s.d., normalized to mock treated cells ( e, f ) Quantification of TMEV replication after infection in Dgcr8 ( e ) and Dicer ( f ) parental (+/+), deficient (-/-) and rescued (resc) cell lines. Data are normalized to miRNA-deficient cell lines susceptibility. Data show the average (n = 3)±s.d (*) p-value<0.05 by t-test. Northern blots for three stem-cell specific miRNAs, as control for knock-out and rescue of Dgcr8 and Dicer , are shown at the right of each panel.
Techniques Used: Infection, Expressing, Inhibition, Quantitative RT-PCR, Northern Blot, Control, Knock-Out
Figure Legend Snippet: ( a ) RT-PCR of poly(I:C) activated ESCs. Only Dgcr8 -/- (lane 6, left panel) and Dicer -/- ( lane 5 and 6, right panel) express detectable Ifnb1 transcript (top panels). Actb amplification serves as a loading control. ( b ) Ifnb mRNA quantification by qRT-PCR after increasing amounts of poly(I:C) in Dgcr8 -/- and Dicer -/- mESCs. Data show the average (n = 3)±s.d., normalized to mock, (*) p-value<0.05 by t-test. ( c ) IFN-β ELISA analyses from mock and poly(I:C) stimulated wild-type and miRNA-deficient ESCs. Data show the average (n = 3)±s.d., (*) p-value<0.05 by two-tailed T test ( d ) TMEV vRNA quantification in wild-type and miRNA-deficient cell lines after mock or Ruxolitinib treatment (JAK1/2 inhibitor). Data show the average (n = 3)±s.d., (*) p value < 0.05 by Student’s t-test, n.s. non-significant ( e ) TCID50 quantification after TMEV infection of Dgcr8 (left) and Dicer (right) rescued cell lines.
Techniques Used: Reverse Transcription Polymerase Chain Reaction, Amplification, Control, Quantitative RT-PCR, Enzyme-linked Immunosorbent Assay, Two Tailed Test, Infection
Figure Legend Snippet: ( a, b ) Susceptibility of Dgcr8 -/- , Dicer -/- and parental cells to TMEV infection after inhibition of IRF3 (BX795) ( a ) and Nf-κB (BMS345541) ( b ), normalized to mock-treated cells. ( c ) Heat map of significantly differentially expressed proteins (p<0.05) in the absence ( Dgcr8 -/- ) or presence ( Dgcr8 resc ) of miRNAs identified by STRING analysis. ( d ) Western blot analysis of MAVS expression in miRNA-deficient cells ( Dgcr8 -/- and Dicer -/- , lanes 2 and 5), wild-type counterparts ( Dgcr8 +/+ and Dicer +/+ , lanes 1 and 4) and respective rescued ESCs lines ( Dgcr8 resc and Dicer resc , lanes 3 and 6). MAVS quantification normalized to Tubulin and relative to wild-type levels is shown at the top of the panel. 10.7554/eLife.44171.010 Figure 3—source data 1. Source data of mass spectrometry results.
Techniques Used: Infection, Inhibition, Western Blot, Expressing, Mass Spectrometry
Figure Legend Snippet: ( a ) Treatment of mESCs with inhibitors of IRF3 and NF-κB activation improves viral replication to a much greater extend in the Dgcr8 -/- and Dicer -/- cells compared to the parental cells, suggesting that the inhibitory effect that miRNAs have on the IFN response is upstream of these two transcription factors. ( b ) Western blot analyses of phospho-IRF3 upon stimulation of Dgcr8 -/- ESCs with poly(I:C) in the presence or absence of BX759 (inhibitor IRF3 phosphorylation). Tubulin serves as a loading control ( c ) Quantification of Tnf mRNA upon poly(I:C) stimulation in Dgcr8 +/+ and Dgcr8 -/- in the presence or absence of BMS345541 (inhibitor of NFkB activation). Data show the average (n = 2) normalized to Gapdh ( d ) Quantification of oxidative phosphorylation activity by Rhodamine 123 uptake assay in Dgcr8 (left) and Dicer (right) cell lines. ( e ) qRT-PCR quantification of Mavs mRNA. Mavs expression is higher in the absence of miRNAs ( Dgcr8 -/- and Dicer -/- ), when compared to parental cell lines ( Dgcr8 +/+ and Dicer +/+ ). Data show the average (n = 3)±s.d, (*) denotes p<0.05, t-test. ( f ) Western blot analyses for MDA5, RIG-I and PKR for wild-type cell lines (+/+), Dgcr8 and Dicer KO (-/-), and the respective rescued cell lines (resc). Quantification of the signal normalized to Tubulin and relative to wild-type is shown at the top of each panel.
Techniques Used: Activation Assay, Western Blot, Phospho-proteomics, Control, Activity Assay, Quantitative RT-PCR, Expressing
Figure Legend Snippet: ( a ) Dual luciferase assay with Mavs , Rig-I and Mda5 3’UTRs in miRNA-deficient cells lines ( Dgcr8 -/- and Dicer -/- ). Data show the average (n = 3)±s.d normalized to Renilla and relative to the parental lines, (*) p-value<0.05 by t-test ( b ) Western blot of cell line overexpressing MAVS lacking the 3’UTR in Dgcr8 +/+ cells (lane 3). MAVS quantification normalized to Tubulin and relative to wild-type is shown at the top ( c ) Susceptibility (TCID 50 /ml) of same cells lines as in ( b ) to TMEV infection (left panel) and quantification of viral RNA after TMEV infections in the same cell lines (right panel). Data show the average (n = 5)±s.d. (*) p-value<0.05 by t-test ( d ) Ifnb mRNA expression after poly(I:C) transfection of the same cell lines as in ( b ), average is represented (n = 3)±s.d, normalized to Dgcr8 +/+ cell line, (*) p-value<0.05 by t-test.
Techniques Used: Luciferase, Western Blot, Infection, Expressing, Transfection
Figure Legend Snippet: ( a ) Transfection of miRNA mimics miR-125a-5p, miR-125b-5p, miR-185–5p and miR-673–5p in Dgcr8 -/- cells followed by MAVS western blot. MAVS quantification normalized to Tubulin and relative to wild-type is shown at the top ( b ) Quantification of TMEV replication by qRT-PCR in the same cell lines as in ( a ) (n = 3) ( c ) Western blot analysis of MAVS expression in Dgcr8 +/+ cells transfected with antagomirs against miR-125a-5p, miR-125b-5p and miR-673–5p. MAVS quantification normalized to Tubulin and relative to wild-type is shown at the top ( d ) Western blot analysis of MAVS expression in miR-673 -/- cell lines. MAVS quantification normalized to Tubulin and relative to wild-type is shown at the top ( e ) Quantification of TMEV vRNA in miR-673 CRISPR knock-out cell lines in a Dgcr8 +/+ background. Data show the average (n = 3)±s.d (*) p-value<0.05 by t-test. ( f ) Quantification of TMEV vRNA shown as fold-change compared to mock upon JAK1/2 inhibition by Ruxolitinib treatment. Data show the average (n = 3)±s.d ( g ) qRT-PCR quantification of mmu-miR-673–5p expression after retinoic acid (RA) differentiation of ESC. Data show the average (n = 2)±s.e.m, normalized to U6 snRNA, (*) p-val <0.05 by t-test.
Techniques Used: Transfection, Western Blot, Quantitative RT-PCR, Expressing, CRISPR, Knock-Out, Inhibition
Figure Legend Snippet: ( a ) Dgcr8 -/- cells were transfected with miRNA mimics for 24 hr, followed by RNA extraction and Mavs mRNA quantification by qRT-PCR. Transfection of all miRNA mimics result in (non-significant) decrease of Mavs levels. ( b ) Dgcr8 -/- mESCs were first transfected with mimics, as in ( a ) followed by TMEV infections 36 hr later, and measurement of the TCID50. All mimics except for mir-185-5p resulted in higher TCID50 values compared to mock transfected cells, suggesting that in mESC cells targeting Mavs with these miRNAs leads to a higher susceptibility to viral infection.
Techniques Used: Transfection, RNA Extraction, Quantitative RT-PCR, Infection
Figure Legend Snippet: ( a ) Genomic sequencing of miR-673 locus contained in chromosome 12. In WT, the position of the two miRNAs encoded by the locus, miR-673–5p and miR-673–3p are indicated by yellow boxes. For miR-673 -/- clones (1,2 and 3) both sequenced alleles are shown with the indicated deletions induced by CRISPR. ( b ) Quantification of mmu-miR-673–5p abundance by qRT-PCR. Data show the average (n = 3)±s.d, normalized to U6 snRNA. (n.d, not detected) ( c ) Quantification of Mavs mRNA levels by RT-qPCR. Data show the average of at least (n = 3)±s.d, normalized to Actb , and relative to Dgcr8 +/+ .
Techniques Used: Genomic Sequencing, Clone Assay, CRISPR, Quantitative RT-PCR
Figure Legend Snippet: ( a ) TMEV vRNA quantification in wild-type and miRNA-deficient cell lines after mock or Ruxolitinib treatment (JAK1/2 inhibitor). Data show the average (n = 3)±s.d., (*) p value < 0.05 by Student’s t-test, n.s. non-significant ( b ) Growth curves of ESCs. Data show the average (n = 3)±s.d. ( c ) No obvious morphological changes were observed between wild-type ( Dgcr8 +/+ ) and miR-673-deficient ESCs ( d ) Quantification of Nanog and Pouf5f1 pluripotent markers upon knocking out miR-673 by CRISPR in comparison to wild-type ESCs, data show the average (n = 3)±s.e.m, (n.s.) non-significant by t-test. NIH3T3 serves as a negative control for pluripotent maker expression ( e ) Quantification of Nanog and Pouf51 expression after reintroduction of miR-673 mimics and controls for 24 or 48 hr. Data show the average (n = 3)±s.e.m. (n.s.) non-significant by t-test.
Techniques Used: CRISPR, Comparison, Negative Control, Expressing
